Ticker Launch
Sign inTry it free

SPAC · Merger completed

Health Sciences Acquisitions Corporation 2

Business combination with Orchestra BioMed, Inc.

Health Sciences Acquisitions Corporation 2 is a blank-check company (SPAC) that raised $139.1M in its initial public offering on Aug 5, 2020, listing on Nasdaq Capital Market. It completed its business combination with Orchestra BioMed, Inc. on Jan 26, 2023; the combined company is Orchestra BioMed Holdings, Inc. (OBIO). Morgan Stanley led the IPO, with Chardan and Barclays. Loeb & Loeb advised the SPAC and Kirkland & Ellis advised the underwriters on the IPO.

Orchestra BioMed is a biomedical company whose partnership-enabled business model aims to bring high-impact technologies to patients through risk-reward sharing partnerships. It collaborates with medical device companies to commercialize the products it develops globally.

Status
Merger completed
IPO date
Aug 5, 2020
IPO size
$139.1M
IPO exchange
Nasdaq Capital Market
Target
Orchestra BioMed, Inc.
Announced
Jul 5, 2022
Closed
Jan 26, 2023
Combined company
Orchestra BioMed Holdings, Inc. (OBIO)
IPO underwriters
Morgan Stanley, Chardan and Barclays
SPAC counsel (IPO)
Loeb & Loeb and Maples and Calder
Underwriters' counsel (IPO)
Kirkland & Ellis

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2023